QPS Holdings Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • QPS Holdings's estimated annual revenue is currently $127.4M per year.(i)
  • QPS Holdings's estimated revenue per employee is $201,000

Employee Data

  • QPS Holdings has 634 Employees.(i)
  • QPS Holdings grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$34M1698%N/AN/A
#2
$8.4M42-28%N/AN/A
#3
$68.7M3426%N/AN/A
#4
$49.4M246-10%N/AN/A
#5
$7.8M3944%N/AN/A
#6
$148.3M7388%N/AN/A
#7
$24.7M12313%N/AN/A
#8
$0.8M814%N/AN/A
#9
$9M457%N/AN/A
#10
$3.8M19-50%N/AN/A
Add Company

Bio-Kinetic Clinical Applications, the choice for your next Phase I study, is located in Springfield, MO. Founded in 1994 by Dale Bourg and Dave Koenigsfeld, BKCA has grown from a 12 bed facility to its current capacity of 240 beds with our new expansion. We also have an established relationship with Bio-Kinetic Europe, located in Belfast, North Ireland, to offer you global Phase I capabilities to meet your needs.

keywords:N/A

N/A

Total Funding

634

Number of Employees

$127.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

QPS Holdings's People

NameTitleEmail/Phone
1
Director & Head Global Human ResourcesReveal Email/Phone
2
Sr. VP & GMReveal Email/Phone
3
Director Business Development - West CoastReveal Email/Phone
4
VP; Global Head Translational MedicineReveal Email/Phone
5
Group LeaderReveal Email/Phone
6
Principal ScientistReveal Email/Phone
7
DirectorReveal Email/Phone
8
Director, Lab Services Global Proposal OfficeReveal Email/Phone
9
VP and Global Head DMPKReveal Email/Phone
10
Associate Director Safety AssessmentReveal Email/Phone

QPS Holdings News

2022-04-13 - Diamond Fields Files Amended and Re-stated NI 43-101 ...

Geol (collectively the “QPs”). ... Labola Project and confirming that the QPs are independent from the Company, Moydow Holdings Limited and...

2022-04-06 - Global Appetite (Eating) Disorders Clinical Trials Review 2022 ...

Takeda Pharmaceutical Co Ltd; Tsumura & Co; Insys Therapeutics Inc (Inactive); QPS Holdings LLC; Opiant Pharmaceuticals Inc...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A722-3%N/A
#2
$291.1M7706%N/A
#3
$210.2M8345%N/A
#4
$273M8595%N/A
#5
$272.1M94810%N/A